Lawrence Steinman
Neurology · Palo Alto, CANPI 1568507812
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Octapharma USA, Inc. at 50.1% of the total. 2024 is the largest year on record at $128,020, more than ten times the $7,408 reported in 2019. Among neurology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $4740.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Octapharma USA, Inc.$114K
- TG Therapeutics, Inc.$38K
- Novartis$20K
- E.r. Squibb & Sons, L.L.C.$17K
- Merck$9K
- F. Hoffmann-la Roche AG$8K
- plus $21K from 7 others
Across 36 payments — averaging $69,298 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$2.2M
- Genentech, Inc.$218K
- Travere Therapeutics, Inc.$22K
- TG Therapeutics, Inc.$20K
- Bristol Myers Squibb$6K
What the payments were for
- Consulting fees$88,66739%
- Speaking & faculty fees$122,36254%
- Travel & lodging$6,0343%
- Food & beverage$6740%
- Education$9,7994%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Octapharma USA, Inc. | 1 | $114,105 |
| TG Therapeutics, Inc. | 11 | $38,032 |
| Novartis | 12 | $20,389 |
| E.r. Squibb & Sons, L.L.C. | 7 | $17,111 |
| Merck | 2 | $8,895 |
| F. Hoffmann-la Roche AG | 4 | $8,145 |
| Sanofi Pasteur Inc. | 1 | $6,325 |
| Bristol Myers Squibb | 5 | $5,273 |
| ANI Pharmaceuticals, Inc. | 1 | $4,235 |
| Regeneron | 1 | $3,126 |
| Biogen | 1 | $1,839 |
| EMD Serono, Inc. | 1 | $35 |
| Mallinckrodt Enterprises LLC | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$227,537 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Other neurology in Palo Alto
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.